Tuesday 19 March 2019 ,
Tuesday 19 March 2019 ,
Latest News
  • Election official among 7 shot dead in Rangamati
  • Bangladesh rejects US report on HR, sends protest note
  • 3 killed, several wounded in Dutch tram shooting
  • Never allow anti-liberation forces to be in power again: PM
  • Vote counting in 116 upazilas underway
  • 5 Bangladeshis died in NZ terror attack
22 October, 2018 00:00 00 AM
Print

US scientists create new drug to sustain oxygen-starved hearts

Xinhua
US scientists create new drug to sustain oxygen-starved hearts

US scientists at University of California, San Francisco (UCSF) have developed a new drug that can restore the function of oxygen-starved heart tissue under the conditions of hypoxia, according to the results of a new study released over the weekend, reports Xinhua from San Francisco.

The new drug called OMX-CV was developed by Omniox, Inc., one of the first biotech startups launched in the incubator space on the UCSF’s Mission Bay campus in 2010.

The biopharmaceutical company has been developing oxygen-delivery therapeutics for the treatment of cancer, cardiovascular diseases, trauma and other conditions in which low oxygen levels, or hypoxia, negatively impact disease outcomes.

The new drug does not cause systemic side effects or overcorrect with excessive blood oxygenation, which can itself be toxic. It delivers its precious oxygen cargo only to the tissues that need it most.

The UCSF researchers have tested the treatment and found the new oxygen-delivery therapeutic is capable of restoring the function of oxygen-starved heart tissue in an animal model of global hypoxia.

Their findings were published in the journal PLOS Biology on Thursday.

The tissues of human body can suffer major damage if they are running low on oxygen, and such hypoxic conditions can lead to long-term tissue damage or even heart attacks.

 

Comments

Poll
Today's Question »
State minister for power Nasrul Hamid yesterday said everyone to have access to electricity by June. Do you think the feat achievable by the timeframe?
 Yes
 No
 No Comment
Yes 54.9%
No 41.4%
No Comment 3.7%
Most Viewed
Digital Edition
Archive
SunMonTueWedThuFri Sat
0102
03040506070809
10111213141516
17181920212223
24252627282930
31

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting